ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2 (HER2) is a well-recognised prognostic and predictive biomarker in breast cancer and plays an important role in the diagnosis, staging, and treatment of breast cancer (Cooke et al., 2001).